Member Info for chester18

Yep if forgot about those.

But my point is still relevent to the fact that they would be turning their backs on 5 times the offer of 20p.

I hope that they want what we all want and that's to come away from this feeling fairly treated. But if GH and CB are sweet talked into taking a position within Newcrest there is nothing we can do about it.

This is one time where I want unadulterated greed to kick in.....

Chester.

Would GH and CB take say 20p a share.
GH would end up with £11m and CB £15.5m based on the directors share count on LSE.
If they know that the whole business will probably be worth £1.00 a share in 4 years time GH £55.75m and CB £77.5m.

So are they going to say "oh go in then, let's have the cash" I don't think so.

Chester.

T10 would settle on the 30th but the money would probably have to be in place on the 29th.

If the associated dealing account held other values of shares you could buy up-to the approx value of those other assets on a T10.
So I stand corrected and suggest that tomorrow is probably the day when a T10 trade would clear after the announcement 11.30pm on Wednesday 29th.

So 'deja vu' , lets see what happens tomorrow......

Chester.

Given that todays news was on the best side of positive and for the sake of the following question we also presume that the finances will now be sorted before the beginning of July.

What is a fair Market Capitalization :

For a company with a turnover of £16-£18m in 2020 and a projection for 2021 of £24m T/O giving for the first time a possible position of breakeven.
Then looking towards 2022 with an approximate T/O of £30m and a possible £4-5m profit.

Would an MCap of £200m (£0.17 per share) be surprising?

The current MCap is just £9m ( £0.008 per share).

Is that a fair projection of where we could be in 18 / 24 months time ?

Chester.

Morning all,

Glad I had the forethought or just confidence to move those shares into this years ISA. Great boost for investors and allows us all to be reassured that we will see TRX grow and become a much larger company.

I've still got a long way to go before I reach breakeven on the shares I've bought over the last 5 years. I think even now I won't be level until we hit 5p or 6p.

But that's investing, in five more years I could be looking back on how cheap 5p was. Can but dream....

Main thing today, this is the best piece of news since November last year and makes me believe that we are in a great position to move forward, sort the funding, build the new manufacturing facility and plough on to beyond breakeven and into profits.

Really have a strong positive feel about Tissue Regenix future.

Chester.

More time to sort out finances.

Turnover up 18% in the middle of a pandemic.

$650k to ease with CV-19 restrictions (obviously seen as an important future technology by the US Gov ).

Overheads reduced allowing the company to hold on to more of the generated cash.

Akso, gives enough time for a potential cash raise, which at say 1.4b shares at 1.5p = £20m. I know it sounds like a massive dilution but if the company can then grow to £50m turnover in 3 or 4 years they will be making £5m to £10m profit. Share price would be circa 15p+

This RNS is nothing less that fantastic News.....

Chester.

What about warrants?

Great time to cash in......

Chester.

We should see a big step up in the size of and the number of trades on Thursday. That when the T10 notes (10days to pay) will cover upto the 30th.
All the 10% trades will be pileing in.

So 6p +++ on Friday if not before.

Chester.

Tissue Regenix products are perfect for surgeons and allow better outcomes for patients.
Their manufacturing facility in San Antonio is flat out but cannot keep up with demand even with CV-19 ripping the heart out of all hospital clinical settings. The future economics must predict that given the right investment they will be a great success and be able to pay back any loan inside 3-4 years.

I decided to put my money where my mouth has always been and just placed £10k of shares in my 2020 ISA.

Now all i need is that positive funding RNS....

GLA

Chester.

Hi Paddy and Reddirt

If it is sterilisation that's a lot of equipment and man power to move away from proving up the resource.

Would the Decline be that important at this stage?

Chester

The price of gold in any deal will be an average of where it has been plus a small projection of where it may go.

I'm not up to date on the ebbs and flows of the gold price but I would have thought $1350 per troy ounce would have been a fair price in any deal last year.

So now at the end of 2020 maybe $1500. It will never be the daily spot price.

Chester.

Maldborough, good rounded post.

My thoughts are very similar due mainly to the CV-19 crisis and the lack of a decisive RNS in the last 3 months.

The nearer we get to mid May without news the more twitchy I'll become.
They did have a slim window of opportunity at around 1.5p to ask for new investment and I would have bought the maximum knowing the money would go straight into the building of new labs.

Still have my fingers well and truly crossed that they find enough cash on terms that are fair to us shareholders.

Chester.

I'm not understanding why they are moving so far out and peppering that ground. If it's just a seam then 'nice to find' but not really mineable.
So how wide would that area have to be to make it a valuable part of a mine?

Or, has the main bulk of the mineralisation just got three times as big?

Totally puzzled as to why their out so far. Help anyone!!

Chester.

We will start to see the SP rising from next Wednesday or Thusday because all the traders will be buying on T10 notes.
We've seen this pattern so many times and probably why there was instant dips once each RNS was out.

The last report from NC was by any standards spectacular, the sixth straight excellent drill cores with fantastic grades. Then the price dipped as the 10% ers took their profits.

I think this time it will be different, Newcrest now having 40% gives the stock gravity and it also gives the big players and institutions the confidence to invest not only up to the MRE but to whatever deal GGP do with NC.

So by next Friday the price could be over the mythical 6p and heading northwards towards the 29th.

Chester.

I thought that first post had failed...
Something wrong with LSE at the moment.....

Chester.

Having been a shareholder of Scancell for quite a few years it would not surprise me to find that Prof. Lindy Durrant was putting her knowhow into the fight against CV-19.

I would say it is in her DNA to challenge these biological abortions.

Chester.

From what I've learnt being a Scancell investor I would be very surprised if Prof. Lindy Durrant is not using her wealth of expertise to help in the fight against CV-19.

It's part of her DNA to challenge these particular biological aborations.

Chester.

Rene have been in the fortunate position since July 2015 when they raised £68.4m at 5p (today's equivalent of £5.00 per share).
They have not had to go cap in hand to anyone and have been able to plough their 'own furrow' so to speak.

The last financial update on the 6th Dec 2019 showed the half year figures for the 6 months up-to the 30th Sept 2019 :

Reduced loss for the period of £3.90 million (2018: loss of £5.36 million)
Reduced cash consumed by operations of £5.15 million (2018: £7.54 million)
Upfront payment of £5.40 million, net of withholding tax, received pertaining to licence agreement with Fosun Pharma
Cash, cash equivalents and bank deposits at 30 September 2019 of £21.27 million (31 March 2019: £26.39 million)

We know that Rene are very keen to control cash outflows and only this week said that they have reduced spending even further due to the CV19 Pandemic.

So they don't need to tell the market anything if they choose not to. They have enough cash to see the middle of 2021 and by then you would think Fosun Pharma would be in trials in China which would trigger milestone payments.

My suggestion is that they have adequate cash and with milestone payments to see them well into 2022.

Chester.

Just further to our conversation about Scancells AvidiMab platform.

No doubt some of you will have seen a company called Tiziana Life Sciences have today lodged a patent for approval that could make an impact on one of the severe conditions of CV19.

A quote from their RNS today :

"Development of this novel technology is a step forward toward expediting development of TZLS-501, a fully-human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for treatment of patients infected with COVID-19 (SARS-CoV-2) coronavirus".

So a tie up with Scancell could help them if they found they needed a boost to make it work.

Chester.

Hi KT

I ran my own company for 20 years and have understood all the twists and turns TRX have been through. I researched the company and really like where they were as they went from £0 to £1m income. At this time Antony Odell was the MD.
When the fund raiser came along and they raised £40m I was more than positive that the company would push on towards breakeven and then yearly profits. I think if Woodford had still been a force he would have backed TRX with more capital and eventually they would have grown into a very valuable player or been taken over at multiple. That I think was how Woodford saw it playing out.

So now due to CV19 circumstances I feel the options to any company in this situation are becoming restrictive and i would have liked the funding to have been dealt with by now.

So I'm being a realist, I don't think its funding or bust, I think there are many alternatives and I'm preparing myself for whatever the details are.

I'm still very positive on TRX and their original product line. If we shrink back to that in a sustainable way I'm ok to still hold on.

Chester.